Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies FiercePharma 21:57 Tue, 28 Apr
Novartis CEO Calls For ‘Complete Rethink’ On Europe Pricing Scrip Pharma Intelligence 17:23 Tue, 28 Apr
Novartis CEO Flags Risks From Trump's Mfn Drug Policy As Q1 Earnings Miss Estimates Benzinga 11:07 Tue, 28 Apr Article paywall
Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen FiercePharma 15:48 Wed, 15 Apr
Anthropic’s oversight trust just hit majority control. The tipping-point was adding Novartis CEO Vas Narasimhan to its board Drug Discovery & Development 05:05 Wed, 15 Apr
Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its board The Economic Times 17:52 Tue, 14 Apr
